Torsten Haferlach

Torsten Haferlach leads the Munich Leukemia Laboratory and has made significant contributions to the genomic characterization of hematologic malignancies that informs donor selection and monitoring strategies for allogeneic cell therapy. His comprehensive leukemia classification systems enable precise patient stratification for allogeneic transplant and emerging off-the-shelf cell therapy approaches. He has pioneered high-throughput diagnostic platforms that support real-time monitoring of engraftment and disease response after allogeneic cell therapy.